Cipher Pharmaceuticals GAAP EPS of $0.21 beats by $0.08, revenue of $12.83M misses by $0.53M
Source: SeekingAlpha
2025-11-06 17:51:02 ET
More on Cipher Pharmaceuticals
- Halvio Capital adds Mestek, exits Daktronics in Q3
- Seeking Alpha’s Quant Rating on Cipher Pharmaceuticals
- Historical earnings data for Cipher Pharmaceuticals
- Financial information for Cipher Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Cipher Pharmaceuticals GAAP EPS of $0.21 beats by $0.08, revenue of $12.83M misses by $0.53M
Companhia Siderurgica Paulista Nova Cosipa
NASDAQ: CPHRF
CPHRF Trading
0.72% G/L:
$11.0595 Last:
1,050 Volume:
$10.54 Open:
CPHRF Latest News
March 04, 2026 05:00:00 pm
Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call
January 28, 2026 08:30:00 am
Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba(TM) (Spinosad)
October 29, 2025 05:00:00 pm
Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call
CPHRF Stock Data
$276,264,909
14,711,856
0.98%
3
11427%
Pharmaceuticals
Healthcare
CA
Mississauga
